Altered gut microbiota and untargeted metabolomic features in patients with schizophrenia: a case–control study
BackgroundMental disorders are among the leading causes of global disease burden, and their etiology spans genetic, environmental, and physiological factors. Emerging evidence suggests that the gut microbiota may contribute to the development of neuropsychiatric disorders through the microbiota–gut–brain axis. This study aimed to characterize differences in gut microbial composition and…
Read original article on Frontiers in Psychiatry | New and Recent Articles →Related news
-
Characterizing the efficacy of zuranolone across patient subgroups and symptom domains in Japanese patients with major depressive disorder: a pooled analysis of two placebo-controlled trials
Switzerland
-
Psychopathy is a key to integrating dimensional personality disorder constructs and psychotherapy: toward a reformulation of personality and its disruption
Switzerland
-
Repositioning community-based mental health care for people with psychosocial disabilities: a physical health equity–oriented whole-health recovery framework
Switzerland
-
Moral engine model: conceptualizing moral injury as a wound to the self caused by rupturing of defining and sustaining emotional attachments
Switzerland
-
Outcome indicators used in recovery college effectiveness studies: a scoping review
Switzerland
-
Systematic review and meta-analysis on the efficacy and safety of combining repetitive transcranial magnetic stimulation with sertraline for adolescent depression in China
Switzerland
-
Psychotic symptom burden and serum uric acid as correlates in a limited-adjustment analysis of current suicidal ideation in schizophrenia: a cross-sectional study
Switzerland
-
Lived experiences of adolescent girls following child sexual abuse: disclosure, coping, and perceived school support
Switzerland